Therefore, these findings indicated that PGD2 and CRTH2 might be potential diagnostic biomarkers and prognostic predictors in DLBCL patients, and further interrogations with more enrolled patients are warranted to confirm the prognostic role of PGD2 and CRTH2 in DLBCL. This evidence concerns the gene PTGDR2 and diffuse large B-cell lymphoma.